Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CERN
301
DELISTED
Cerner Corp
CERN
| $46.2M | 0.08% |
+748,404
| New | +$47.2M |
2016 Q3
0 quarters
|
|
302
United Therapeutics
UTHR
$22.9B
| $46.1M | 0.08% |
390,100
-14,200
| -4% | -$1.71M |
2013 Q2
13 quarters
|
|
|
BLOX
303
DELISTED
Infoblox Inc
BLOX
| $46M | 0.08% |
1,744,400
+510,900
| +41% | +$10.8M |
2014 Q1
10 quarters
|
|
304
Canadian Imperial Bank of Commerce
CM
$98.2B
| $46M | 0.08% |
1,186,042
+678,642
| +134% | +$26.1M |
2013 Q2
13 quarters
|
|
305
Workday
WDAY
$45.3B
| $45.9M | 0.08% |
500,800
+241,100
| +93% | +$20.1M |
2016 Q2
1 quarter
|
|
306
Xerox
XRX
$383M
| $45.9M | 0.08% |
1,717,916
+1,196,525
| +229% | +$30.9M |
2016 Q2
1 quarter
|
|
|
SBY
307
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $45.7M | 0.08% |
2,608,600
+356,600
| +16% | +$6.51M |
2014 Q2
9 quarters
|
|
|
MODV
308
DELISTED
ModivCare
MODV
| $45.5M | 0.08% |
934,807
+19,507
| +2% | +$915K |
2013 Q2
13 quarters
|
|
|
ISBC
309
DELISTED
Investors Bancorp, Inc.
ISBC
| $45.4M | 0.08% |
3,780,925
-911,353
| -19% | -$10.6M |
2013 Q2
13 quarters
|
|
|
WCN
310
Waste Connections
WCN
$38.9B
| $45.4M | 0.08% |
910,790
-957,750
| -51% | -$48.3M |
2013 Q4
11 quarters
|
|
|
PDLI
311
DELISTED
PDL BioPharma, Inc.
PDLI
| $45.1M | 0.08% |
13,472,854
+907,200
| +7% | +$2.88M |
2013 Q2
13 quarters
|
|
312
Allstate
ALL
$58.3B
| $44.9M | 0.08% |
649,000
+184,400
| +40% | +$12.7M |
2015 Q4
3 quarters
|
|
313
InterDigital
IDCC
$8.47B
| $44.9M | 0.08% |
566,893
+60,500
| +12% | +$4.04M |
2013 Q2
13 quarters
|
|
314
Boston Scientific
BSX
$60.9B
| $44.8M | 0.08% |
1,884,005
-3,017,900
| -62% | -$72M |
2015 Q4
3 quarters
|
|
315
NETGEAR
NTGR
$631M
| $44.7M | 0.08% |
739,600
-1,700
| -0.2% | -$92.5K |
2014 Q4
7 quarters
|
|
316
Brady Corp
BRC
$3.96B
| $44.6M | 0.08% |
1,288,500
+209,700
| +19% | +$6.91M |
2014 Q3
8 quarters
|
|
317
REX American Resources
REX
$1.49B
| $44.5M | 0.08% |
3,153,600
-4,800
| -0.2% | -$58.4K |
2013 Q2
13 quarters
|
|
318
CenterPoint Energy
CNP
$25.3B
| $44.5M | 0.08% |
1,917,600
+1,023,500
| +114% | +$23.9M |
2014 Q2
9 quarters
|
|
319
Leidos
LDOS
$15B
| $44.5M | 0.08% |
1,027,950
+623,300
| +154% | +$28.3M |
2014 Q4
7 quarters
|
|
|
MLNX
320
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $44.3M | 0.08% |
1,025,283
+240,700
| +31% | +$10.7M |
2015 Q1
6 quarters
|
|
321
MGIC Investment
MTG
$5.72B
| $44M | 0.08% |
5,498,700
+3,393,500
| +161% | +$25.2M |
2014 Q4
7 quarters
|
|
322
Tyson Foods
TSN
$18.4B
| $43.9M | 0.08% |
587,700
+193,500
| +49% | +$14.2M |
2015 Q4
3 quarters
|
|
|
GRMN
323
Garmin
GRMN
$51.8B
| $43.8M | 0.08% |
909,742
+828,342
| +1,018% | +$40.9M |
2015 Q1
6 quarters
|
|
324
Campbell Soup
CPB
$5.78B
| $43.5M | 0.08% |
796,000
+780,000
| +4,875% | +$47.2M |
2015 Q3
4 quarters
|
|
325
Berkshire Hathaway Class B
BRK.B
$1.09T
| $43.5M | 0.08% |
300,900
+293,900
| +4,199% | +$43M |
2014 Q4
7 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.